|
|
|
|
| LEADER |
01349naa a2200337 i 4500 |
| 001 |
NSK01001089885 |
| 003 |
HR-ZaNSK |
| 005 |
20220128173207.0 |
| 007 |
ta |
| 008 |
210209s2018 ci a | |0|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)001089885
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 615
|2 2011
|
| 100 |
1 |
|
|a Wu, Tong
|4 aut
|9 HR-ZaNSK
|
| 245 |
1 |
0 |
|a Development and evaluation of orally disintegrating tablets containing the mosapride resin complex /
|c Tong Wu, Guanhua Wang, Caihong Shi, Jinghan Li, Na Zhao, Zihao Dong, Weisan Pan, Xiangrong Zhang.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 22 jed.
|
| 653 |
|
0 |
|a Oralna primjena lijeka
|a Razvoj lijekova
|a Mozaprid
|a Adsorpcija
|a Smola
|a Amberlit
|a Fizikalno-kemijska svojstva
|a Orodisperzibilne tablete
|a Vrijeme razgradnje
|a Disfagija
|
| 700 |
1 |
|
|a Wang, Guanhua
|4 aut
|9 HR-ZaNSK
|
| 700 |
1 |
|
|a Shi, Cai-Hong
|4 aut
|
| 700 |
1 |
|
|a Li, Jinghan
|4 aut
|9 HR-ZaNSK
|
| 700 |
1 |
|
|a Zhao, Na
|4 aut
|9 HR-ZaNSK
|
| 700 |
1 |
|
|a Dong, Zihao
|4 aut
|9 HR-ZaNSK
|
| 700 |
1 |
|
|a Pan, Weisan
|4 aut
|9 HR-ZaNSK
|
| 700 |
1 |
|
|a Zhang, Xiang-Rong
|4 aut
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 68 (2018), 2 ; str. 159-170
|w nsk.(HR-ZaNSK)000054908
|
| 981 |
|
|
|b B07/18
|
| 998 |
|
|
|b gtao2102
|
| 856 |
4 |
1 |
|u https://hrcak.srce.hr/193570
|y Elektronička verzija članka
|